Pacira BioSciences Inc (PCRX)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell
$17.76
Buy
$32.00
$-0.03 (-0.12%)
Pacira Pharmaceuticals Inc is a specialty and generic drug manufacturing company. The company develops, manufactures, and commercializes pharmaceutical products for use in hospitals and ambulatory surgery centers across the United States.
Prices updated at 12 May 2025, 09:45 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Ms. Laura A. Brege
CEO
Mr. Frank D. Lee
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
790
Head office
5401 West Kennedy Boulevard
Tampa
United States
33609
Key personnel
| Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
|---|---|---|---|---|---|
Ms. Laura A. Brege Chairman of the Board | 0.09m | - | - | 0.39m | - |
Mr. Brendan P. Teehan Chief Commercial Officer | - | - | - | - | - |
Mr. Daryl Gaugler Executive Vice President, Commercial Operations | 0.51m | 0.24m | - | 3.59m | - |
Ms. Krys Corbett Chief Business Officer | - | - | - | - | - |
Dr. Mark A. Kronenfeld, M.D. Independent Director | 0.09m | - | - | 0.39m | - |
Ms. Kristen Marie Williams Chief Administrative Officer and Secretary | 0.52m | 0.25m | - | 3.61m | - |
Mr. Michael J. Yang Independent Director | 0.07m | - | - | 0.37m | - |
Dr. Mark I. Froimson, M.D. Independent Director | 0.07m | - | - | 0.37m | - |
Mr. Abraham N. Ceesay, M.B.A. Independent Director | 0.06m | - | - | 0.36m | - |
Governor Christopher J. Christie Independent Director | 0.05m | - | - | 0.35m | - |
Mr. Shawn M. Cross Chief Financial Officer | 0.10m | 0.05m | - | 2.74m | - |
Mr. Frank D. Lee Director and Chief Executive Officer | 0.90m | 0.69m | - | 15.94m | - |
Mr. Jonathan Slonin Chief Medical Officer | 0.54m | 0.25m | - | 2.88m | - |
Ms. Alethia Young Independent Director | 0.07m | - | - | 0.37m | - |
Dr. Marcelo Bigal, M.D.,PhD Independent Director | 0.07m | - | - | 0.37m | - |
Top 5 shareholders
| Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
|---|---|---|---|---|---|---|
| BlackRock Inc | 7,709,819 | 0.00294 | -77580 | -0.996225 | 30 Apr 2025 | 16.66 |
| Vanguard Group Inc | 5,263,919 | 0.00173 | -34764 | -0.656088 | 30 Apr 2025 | 11.37 |
| BlackRock Fund Advisors | 5,049,935 | 1.26159 | -26956 | - | 30 Apr 2025 | 10.91 |
| Pacer Advisors, INC. | 3,262,837 | 0.13261 | -1699384 | -34.246439 | 30 Apr 2025 | 7.05 |
| iShares Core S&P Small-Cap ETF | 2,803,671 | 0.10211 | -2784 | -0.0992 | 30 Apr 2025 | 6.06 |
Director dealings
| Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
|---|---|---|---|---|---|---|---|
| 31 Dec 2024 | - | Mr. Daryl Gaugler | 16.01 | 3,900 | 115,443 | - | - |
| 13 Dec 2024 | - | Mr. Daryl Gaugler | 19.76 | 9,880 | 115,200 | - | - |
| 04 Nov 2024 | - | Mr. Shawn M. Cross | - | - | 200,000 | - | - |
| 01 Nov 2024 | - | Mr. Shawn M. Cross | - | - | 75,000 | - | - |
| 13 Sep 2024 | - | Mr. Daryl Gaugler | 12.86 | 6,430 | 115,700 | - | - |
| 16 Aug 2024 | - | Ms. Laura A. Brege | 12.81 | 12,810 | 17,552 | - | - |
| 16 Aug 2024 | - | Dr. Marcelo Bigal, M.D.,PhD | 13.25 | 20,034 | 10,142 | - | - |
| 14 Aug 2024 | - | Mr. Michael J. Yang | 12.90 | 25,800 | 7,230 | - | - |
| 12 Aug 2024 | - | Dr. Mark I. Froimson, M.D. | 11.58 | 16,212 | 14,473 | - | - |
| 12 Aug 2024 | - | Mr. Frank D. Lee | 12.10 | 99,994 | 107,784 | - | - |
| 12 Aug 2024 | - | Dr. Marcelo Bigal, M.D.,PhD | 12.01 | 40,834 | 8,630 | - | - |
| 02 Aug 2024 | - | Mr. Jonathan Slonin | 20.05 | 18,947 | 94,307 | - | - |
| 01 Aug 2024 | - | Mr. Jonathan Slonin | 20.75 | 6,329 | 95,252 | - | - |
| 01 Jul 2024 | - | Mr. Jonathan Slonin | 28.46 | 26,012 | 98,393 | - | - |
| 28 Jun 2024 | - | Mr. Jonathan Slonin | 24.32 | 10,634 | 99,307 | - | - |
| 02 Jul 2024 | - | Mr. Jonathan Slonin | 28.25 | 80,117 | 95,557 | - | - |
| 28 Jun 2024 | - | Mr. Daryl Gaugler | 24.32 | 3,900 | 116,200 | - | - |
| 12 Jun 2024 | - | Ms. Laura A. Brege | - | - | 12,179 | - | - |
| 12 Jun 2024 | - | Ms. Laura A. Brege | - | - | 16,552 | - | - |
| 13 Jun 2024 | - | Mr. Paul J. Hastings | 28.38 | 24,974 | 12,724 | - | - |
Please note that past performance is not a reliable indicator of future returns.
